Skip to main content

Brown Jeffrey J's Form 4 filing

Medifast Inc (MED) · filed Nov 10, 2021

Accession no.
0001104659-21-137193
Filed
Nov 10, 2021
Trade date
Nov 8, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 10 non-derivative transactions. Open-market purchases total $973.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Brown Jeffrey JCIK 0001245377Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 8, 2021Common StockPPurchaseAcquired+199.9$218.49+$43,676.1530,957.15Indirect
Nov 8, 2021Common StockPPurchaseAcquired+160$224.96F2+$35,993.631,117.15Indirect
Nov 8, 2021Common StockPPurchaseAcquired+200$226.68F3+$45,33631,317.15Indirect
Nov 8, 2021Common StockPPurchaseAcquired+200$227.78F4+$45,55631,517.15Indirect
Nov 8, 2021Common StockPPurchaseAcquired+290$229.91F5+$66,673.931,807.15Indirect
Nov 8, 2021Common StockPPurchaseAcquired+150$231.65F6+$34,747.531,957.15Indirect
Nov 8, 2021Common StockPPurchaseAcquired+807$232.55F7+$187,667.8532,764.15Indirect
Nov 8, 2021Common StockPPurchaseAcquired+593$233.68F8+$138,572.2433,357.15Indirect
Nov 8, 2021Common StockPPurchaseAcquired+1,000$234.52F9+$234,52034,357.15Indirect
Nov 8, 2021Common StockPPurchaseAcquired+600$235.28F10+$141,16834,957.15Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $224.67 USD to $225.45 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $226.51 USD to $226.85 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $227.61 USD to $227.95 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $229.75 USD to $230.13 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $231.57 USD to $231.82 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $232.00 USD to $232.99 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $233.12 USD to $233.96 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $234.11 USD to $234.99 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

F10

This transaction was executed in multiple trades at prices ranging from $235.00 USD to $235.71 USD; the price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)